Canadian Stroke Best Practice Recommendations STROKE PREVENTION WRITING GROUP 2017:

Transcription

1 Canadian Stroke Best Practice Recommendations STROKE PREVENTION WRITING GROUP 2017: NAME PROFESSIONAL ROLE LOCATION DECLARED CONFLICTS OF INTEREST Wein, Theodore Gladstone, David Côté, Robert Berlingieri, Joseph Co-Chair, Assistant Professor of Neurology and Neurosurgery, McGill University Stroke Prevention Clinic, Montreal General Hospital Associate Professor, Department of Medicine (Neurology), University of Toronto; Director, Regional Stroke Prevention Clinic, Sunnybrook Health Sciences Centre, Toronto Stroke Neurologist, Professor, Department of Neurology, Neurosurgery and Medicine; McGill University Health Centre Internist and Intensivist; Medical Co-Director of JBN Medical Diagnostic Services (private stroke prevention clinic in Burlington, linked to Hamilton stroke program; brings community perspective) Quebec Potential Conflict: BoehringherIngelheim Research, Speaker, Travel Potential Conflict: Bayer Research, Speaker, Travel Potential Conflict: Allergan Inc Research, Consultant, Potential Conflict: Servier Research, Speaker Potential Conflict:Bayer, Boehringer-Ingelheim, Bristol Myers Squibb, Pfizer : speaker fees for CME events and/or honouraria for advisory boards Potential Conflict: EMRACE trial and SCREEN-AF trial Principal Investigator Quebec Pfizer/BMS Speaker honorarium Potential or Actual Conflict of Interest Area of oral anticoagulants Bourgoin, Aline Stroke Prevention Coordinator, Nurse Specialist Stroke Prevention Clinic Champlain Regional Stroke Network, Buck, Brian H. Vascular Neurologist, Assistant Professor, Division of Neurology, Department of Medicine, University of Alberta Alberta : Bayer : Speaker honorarium, advisory board Potential or Actual Conflict of Interest Area of oral anticoagulants CSBPR Sixth Edition Final 25October2017 Page 1 of 6

2 Cox, Jafna Cardiologist; Heart and Stroke Foundation of Endowed Chair in Cardiovascular Outcomes Research Professor of Medicine and of Community Health and Epidemiology, Dalhousie University Potential conflict for the following: Company/OrganizationName Bayer (relationship to until present) Funded research, speaker, advisory board member BoehringerIngelheim (no relationship for 3 years) Speaker, Advisory Board Member BMS Pfizer, no relationship for less than 1 year Speaker, Advisory Board Member Davidson, Dion Vascular Surgeon Valley Regional Hospital Douketis, Jim Internist and Thrombosis Specialist; Divisions of General Internal Medicine, Hematology and Thromboembolism, McMaster University Department of Medicine; President of Thrombosis Canada ( Participant in Advisory Boards or Educational Activities for following companies: Bayer ( ); Bristol- Myers-Squibb ( ); Sanofi ( ); Astra-Zeneca (before 2008); Boehringer-Ingelheim ( ); Pfizer ( ); Biotie (2013); Portola (2012); The Medicines Co. ( ); Daiichi- Sankyo (2015). Consultant to following companies Actelion (2014); AGEN Biomedical ( ); Ortho-Janssen Pharmaceuticals ( ); Boehringer-Ingelheim ( ); Janssen Pharmaceuticals (2014-present); Grant support from following companies: Boehringer-Ingelheim (2014) Falconer, John Internist; UBC Clinical Associate Professor of Medicine; Director Kelowna General Hospital TIA/Stroke Unit; Course Director Foundations of Medicine UBC Southern Medical Program British Columbia Field, Thalia Stroke Neurologist; Assistant Professor, Faculty of Medicine, University of British Columbia Stroke Neurologist, Vancouver Stroke Program British Columbia Potential Conflict: Bayer Canada and Bayer Global : Advisory Board and Speakers' Bureau, research methodology training program participation CSBPR Sixth Edition Final 25October2017 Page 2 of 6

3 Gioia, Laura Stroke Neurologist Assistant Professor Department of Neurosciences, CHUM-Centre Hospitalier de l Université de Montréal Hôpital Notre Dame Potential Conflict: BoehringerIngleheim Funded research Quebec Potential Conflict: Bayer Canada and Bayer Global : Advisory Board Habert, Jeffrey Family Physician, Assistant Professor, University of Toronto, Dept. Of Family And Community Medicine Potential Conflict: Bayer, Bristol-Myers- Squibb, Boehringer-Ingelheim, Pfizer, Eli-Lilly, Astra-Zeneca, Janssen, Novo- Nordisk Jaspers, Sharon Lum, Cheemun Nurse Practitioner, Stroke Prevention Clinic, Thunder Bay Regional Health Sciences Centre Faculty, Northern School of Medicine Neuroradiologist; Section Head, Interventional Neuroradiology, The Ottawa Hospital : Advisory Board/Speaker Potential Conflict: Bayer,BoehringerIngelheim, Pfizer : speaker/workshop: honorarium McNamara Morse, Dana Nurse Practitioner, Stroke Program, Valley Regional Hospital Pageau, Paul Emergency Physician, The Ottawa Hospital Assistant Professor, Department of Emergency Medicine, The University of Ottawa Rafay, Mubeen Paediatric Stroke Neurologist, Winnipeg Children s; University of Manitoba; Paediatric Stroke Writing Group Manitoba Rodgerson, Amanda Clinical Stroke Dietitian Provincial Acute Stroke Unit and Provincial Rehabilitation Unit, Queen Elizabeth Hospital PEI Semchuk, Bill Manager, Clinical Pharmacy, Clinical Pharmacist, Regina Lipid Clinic; Regina Qu Appellle Health Region Saskatchewan Potential Conflict, Paid Speaker for: BoheringerIngelheim, Bayer and BMS Pfizer CSBPR Sixth Edition Final 25October2017 Page 3 of 6

4 Shoamanesh, Ashkan Stroke Neurologist; Assistant Professor of Medicine (Neurology); Director, Stroke Fellowship Program; Marta and Owen Boris Chair in Stroke Research and Care McMaster University / Population Health Research Institute Potential Conflict: Bayer HealthCare Pharmaceuticals Research Stipend for Ongoing Committee Involvement in the NAVIGATE ESUS trial Tamayo, Arturo Stroke Neurologist; Brandon Regional Hospital, Winnipeg Health Sciences Centre; University of Manitoba Manitoba Potential conflict, Speaker for: Bayer, BoehringerIngelheim and Bristol- Myers Squibb CSBPR Sixth Edition Final 25October2017 Page 4 of 6

5 Canadian Stroke Best Practice Recommendations STROKE PREVENTION EXTERNAL REVIEWERS 2017: Secondary Prevention of Stroke CCS 2016 Lipid Guidelines EXTERNAL REVIEWER Dr. Natan Bornstein PROFESSIONAL ROLE Professor of Neurology at the Tel-Aviv University, Sackler Faculty of Medicine Head of Stroke Unit at the Tel-has Aviv Medical Center LOCATION Israel DECLARED CONFLICTS OF INTEREST Pfizer Israel Consultation fees Bayer Israel Consultation fees Company/Organization Boehringer Ingelheim Israel Lecture Bureau Company/Organization Amgen Advisory Board- Honorarium Dr. Seemant Chaturvedi Dr. Marion Cornish Dr. Jamsheed Desai Dr. Robert Hart Professor of Clinical Neurology; Vice Chair Neurology Programs; Miami VA Medical Center; Stroke Division Internist, Critical Care and Geriatric Medicine; Valley Regional Hospital Stroke, Neuromuscular and General Neurology, Trillium Health Partners Mississauga; Assistant Professor at McMaster University and Lecturer at the University of Toronto. Professor of Medicine in the Division of Neurology at McMaster University; Staff Physician at Hamilton Health Sciences, Hamilton General Hospital; Senior Scientist at Population Health Research Institute United States Potential Conflicts Boehringer Ingelheim Funded researcher Potential Conflict Bristol-Myers Squibb CME events, paid speaker Potential Conflicts Bayer AG Sponsored research with personal stipend; consultancy. Bristol Myers-Squibb sponsored research with personal stipend CSBPR Sixth Edition Final 25October2017 Page 5 of 6

6 Dr. Adam Kirton Dr. Lewis B. Morgenstern Associate Professor, Pediatrics and Clinical Neurosciences, Faculty of Medicine, University of Calgary, Alberta Children s Hospital Research Institute (ACHRI), Director Calgary Pediatric Stroke Program Pediatric Associate Chair of Neurology for Faculty Development and Finance; Director of the Stroke Program; Professor of Neurology, Epidemiology, Emergency Medicine and Neurosurgery; The University of Michigan Medical School and School of Public Health Alberta United States Secondary Prevention of Stroke CCS 2016 Lipid Guidelines Michelle Slapkauskas RN BScN; Belleville General - Stroke Prevention Clinic Dr. David Spence Dr. Luciano A. Sposato Thomas Stewart MD, FRCPC Professor of Neurology and Clinical Pharmacology Director, Stroke Prevention & Atherosclerosis Research Centre (SPARC) Robarts Research Institute MD, MBA; Associate Professor of Neurology; University of Western Manager, Pre-Admission and Stroke Prevention Clinic Regina Saskatchewan Saskatchewan Potential conflicts Boehringer Ingelheim Speaker CSBPR Sixth Edition Final 25October2017 Page 6 of 6